Healthcare BPOC Joins PE Push Into Clinical Trial SitesPrivate equity firms are creating clinical trial platforms to roll up independents in a highly fragmented industry. January 9, 2024
Healthcare Biotech Milestones: Almost Always Included, Almost Never HitMost biopharma deals are for companies without any products on the market, which require FDA approval after costly and time-consuming clinical trials. November 10, 2023
Advent, Warburg Pincus Name Franco Negron CEO of BioPharmaMost recently, he served for three years as the CEO of ApiJect Systems America. August 24, 2023
Private Equity Dealflow Continued to Dwindle in JulyDeal activity was off more than 50 percent year-on-year last month. August 3, 2023
Private Equity Season of Shelved M&A Surpasses $150B as Credit Woes BiteMore than $150 billion of mergers and acquisitions have been scrapped or stalled since the beginning of June. August 30, 2022
Strategic Buyers Bigger is No Longer Better in Corporate Breakup BoomThe number of companies hiving off divisions is providing opportunities for buyout firms to deploy capital. February 11, 2022
Strategic Buyers Johnson & Johnson to Split into Two CompaniesJ&J’s decision comes just days after General Electric said it would break itself into three pieces. November 12, 2021
Healthcare Roivant Sciences Closes Combination with Montes Archimedes SPACRoivant is a biopharmaceutical company. October 4, 2021